News Article 645 Keck Receives grant March 2014

March 01, 2014

James Keck, PhD, professor of biomolecular chemistry, received an R21/R33 Phased Innovation Award from the National Institutes of Health, National Institute of Allergy and Infectious Diseases. The two-phase award consists of an R21 phase for milestone-driven exploratory studies with the possibility of transitioning to an R33 phase to expand development. The first two years of the grant, totaling $400,000 will transition, if selected, to a three-year R33 phase totaling $1,330,000. The major goal of Keck's grant is to establish protein complex interfaces as targets for the development of new antibacterial lead compounds.